Pharm
Ortho-Tricyclen
search
Ortho-Tricyclen
, OrthoTricyclen, Ortho Tricyclen, Ortho Tri-Cyclen, Tri-Sprintec
See Also
Oral Contraceptive
Oral Contraceptive Drug Interaction
Oral Contraceptive Selection
Oral Contraceptive Side Effect Management
Oral Contraceptive-Related Uterine Bleeding Management
Preparations (Norgestimate / Ethinyl Estradiol)
Ortho Tri-Cyclen (0.18 - 0.215 - 0.250 / 35)
Components
Norgestimate
0.5 to 1.0 (see preparations above)
Ethinyl Estradiol
35 ug
Effect
Relative
Progestational Activity
: 0.3 (low)
Estrogenic Activity
: 35 (moderate)
Androgenic Activity
: 0.15 (low)
Pill associated problems
Indications to switch to
Modicon
Acne Vulgaris
(lower androgen)
Increased Appetite (lower
Progestin
)
Break-through bleed days 1-9 (more
Estrogen
)
Break-through bleed all of month (more
Estrogen
)
Major Depression
provoked (lower
Progestin
)
Menses
too light (more
Estrogen
, less
Progestin
)
Indications to switch to
Demulen 1/35
Breast
Tenderness or engorgement (lower
Estrogen
)
Break-through bleed days 10-21 (more
Progestin
)
Headache
s (lower
Estrogen
)
Heavy
Menses
(more
Progestin
or less
Estrogen
)
Dysmenorrhea
or
Menstrual Cramps
(more
Progestin
)
Moodiness (less
Estrogen
or more
Progestin
)
Weight gain (less
Estrogen
or more
Progestin
)
Indications to switch to
Lo/Ovral
Libido decreased (more androgen)
References
Cerel-Suhl (1999) Am Fam Physician 60(7):2073 [PubMed]
Speroff (1993) Obstet Gynecol 81:1034-47 [PubMed]
Dickey (1998) Managing Contraceptive Pill Patients
Type your search phrase here